Effect of pregabalin in treatment of uremic restless leg syndrome
Not Applicable
- Conditions
- Restless leg syndrome.Other specified extrapyramidal and movement disorders
- Registration Number
- IRCT2017072312685N9
- Lead Sponsor
- Kermanshah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 78
Inclusion Criteria
diagnosis of ESRD; restless leg syndrome; signing of the informed consent.
Exclusion criteria:anemia; iron deficiency; treatment with other restless leg syndrome specific drugs; hypercalcemia; hypocalcemia; sensitivity to pregabalin; patient who reject cooprate for follow up
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of restless legs syndrome symptoms. Timepoint: Beginning and end of study. Method of measurement: International restless legs syndrome study group rating scale(IRLS)questionnaire.
- Secondary Outcome Measures
Name Time Method Drug side effects. Timepoint: The entire study priod. Method of measurement: By patients report.